Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). The purpose of this study is to assess how safe and effective lutikizumab is in adult鈥�
The purpose of this protocol is to evaluate the efficacy of tulisokibart in participants with moderately to severely active ulcerative colitis. Study 1's primary hypotheses are that at least 1 tulisokibart dose level is superior to Placebo in the鈥�
Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most often affecting the bowels. It can cause many different symptoms including abdominal pain, diarrhea, tiredness, and鈥�
13 publications
2022
ACG case reports journal
鈥�2022
Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition
鈥�2022
JPEN. Journal of parenteral and enteral nutrition
鈥�2020
Health equity
鈥�2018
F1000Research
鈥�